Site Advocacy Groups

Why a SAG?

The Site Advocacy Group (SAG) is a landmark industry initiative begun by SCRS that facilitates meaningful dialogue between site professionals and industry leaders on a variety of topics. SAGs are convened at the request of a host organization; sponsor, CRO or professional service provider. The work of the SAG enhances clinical research effectiveness and more closely aligns the work of the sites and industry on current or future projects the host is engaged.

SAG members are comprised of SCRS members representing a broad spectrum of site professionals from around the globe. The composition of the SAG is at the request of the host organization; however, SCRS can offer suggestions of which type of site professionals would best meet the needs of their SAG.

SAG topics have included: Patient Recruitment & Retention, Technology, Protocol and Clinical Topics, Operational Processes, and Site and Business Relationships with Sites.

The knowledge gained provides a unique perspective to help ensure the design and rollout of the most useful solutions for all stakeholders is the result.

SAG Reports

At times the host organization may decide to share the findings of a SAG with the public.  Below are reports which have been shared by host organizations resulting from SAGs.

The Voice of the Study Coordinator: Empowering Clinical Trial Sites to Deliver Improved Performance – inVentiv Health

Contact SCRS today to customize your SAG

Get an Inside Look at Lilly's Site Advocacy Group

Interested in Hosting a SAG?

If you are a sponsor, CRO, or professional service provider interested in hosting a SAG and gathering feedback from sites on an industry-relevant topic, please contact:

Sean Soth
sean.soth@myscrs.org
+1 214.263.1094

How Can My Site Participate in a SAG?

SAG participation is limited to SCRS members. Member sites interested in participating in a SAG are encouraged to contact SCRS:

Michael Jay
michael.jay@myscrs.org
+1 410.696.5080 ext 402

The SAG Impact

“the SAG gave us the opportunity to bring together strong experts with a lot of passion for development excellence – we listened to them very carefully and are taking their insights to heart as we work towards delivering our purpose: breakthroughs that change patients’ lives.’”

Federica Bitonti, Sr. Director, Clinical Site Operations - Global Site and Study Operations, Pfizer Global Product Development

“Gaining perspectives from the SAG helped in understanding what is truly important to sites, rather than us guessing. Their participation and input were invaluable.”

Kelly Kirsch, MPHSAG, Shared Investigator PlatformClinical Development Information and Optimization, Eli Lilly and Company

“The SAG proved incredibly valuable to uncover the site perspective in clinical technology. A key takeaway for us is that we have the power to change how systems are built to align with the workflow at the site – it just requires a shift in mindset and communication between sites, sponsors, CROs and vendors.”

Amy Ripston, Senior Director, Head of Marketing, 4G Clinical